Helga B.
- Country
- Germany
- Department
- Medizinische Klinik V - Onkologie und Hämatologie
Research Overview
- Phase III Randomized Study of CPX-351 Versus Standard Chemotherapy in Adults with Newly Diagnosed AML and Intermediate or Adverse Genetic Risk
- Evaluation of BrECADD Versus Escalated BEACOPP in First-Line Treatment of Advanced Hodgkin Lymphoma: A Randomized Controlled Trial
- Phase III Randomized Trial of Isatuximab Addition to Lenalidomide, Bortezomib, and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients
Data & Insights
Has run more than one trial at 75 of 189 partner sites.
Specializations
Blood Cancers and Hematologic Malignancies
This investigator specializes in treating various blood-related cancers, with particular emphasis on multiple myeloma and acute myeloid leukemia. Their research encompasses innovative therapeutic approaches for newly diagnosed cases.
- Multiple Myeloma Treatment Optimization
- Acute Myeloid Leukemia Management
- Myelodysplastic Syndrome Research
Their work includes evaluation of novel drug combinations and administration methods for enhanced treatment outcomes.
Lymphoma Studies
The investigator conducts research in advanced Hodgkin lymphoma treatment protocols, focusing on developing less toxic therapeutic regimens while maintaining treatment efficacy.
- Treatment-Related Morbidity Reduction
- Progressive Treatment Protocols
- Radiotherapy Integration
Their research aims to optimize treatment outcomes while minimizing adverse effects in lymphoma patients.
Gastrointestinal Oncology
The investigator focuses on treatment strategies for locally advanced rectal cancer, exploring innovative approaches to surgical timing and chemotherapy protocols.
- Pre-surgical Treatment Optimization
- Risk-adapted Therapy Approaches
- Disease-free Survival Enhancement
Their work includes evaluation of various treatment sequences to improve patient outcomes in rectal cancer.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.